CD155 Antibody |
|||
E10-31778 | EnoGene | 100ul | EUR 255 |
Description: Available in various conjugation types. |
Human Antibody Laboratories manufactures the human cd155 neutralizing antibody reagents distributed by Genprice. The Human Cd155 Neutralizing Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact human Antibody. Other Human products are available in stock. Specificity: Human Category: Cd155 Group: Neutralizing Antibody
Anti-CD155 antibody |
||
St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to CD155. |
CD155 Polyclonal Antibody |
||
EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
CD155 Polyclonal Antibody |
||
EnoGene | 100ug | EUR 225 |
Description: Available in various conjugation types. |
CD155 polyclonal antibody |
||
EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
Polyclonal PVR / CD155 Antibody |
||
Leading Biology | 0.05ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PVR / CD155 . This antibody is tested and proven to work in the following applications: |
PVR/CD155 Polyclonal Antibody |
||
Biovision | each | EUR 261.6 |
Rabbit anti-CD155 Antibody |
||
DL Develop | 100 ul | EUR 289 |
Description: PVS; Poliovirus receptor; Nectin-like protein 5; NECL-5; CD155 |
Neutralizing Antibody information
Human Cells anti-COVID-19 S-hIgG1 Neutralizing Antibody |
|||
DL99725A-100ul | DL Develop | 100 ul | EUR 299 |
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein |
Human Cells anti-COVID-19 S-hIgG1 Neutralizing Antibody |
|||
DL99725A-50ul | DL Develop | 50 ul | EUR 210 |
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein |
Monoclonal NGF/proNGF Neutralizing Antibody Antibody |
|||
AMM06679G | Leading Biology | 0.05mg | EUR 633.6 |
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E |
Anti-COVID-19 S-IgM Neutralizing Antibody |
|||
E38A9973 | EnoGene | 100ug/100ul | EUR 225 |
Description: Available in various conjugation types. |
Anti-COVID-19 S-IgA Neutralizing Antibody |
|||
E38A9974 | EnoGene | 100ug/100ul | EUR 225 |
Description: Available in various conjugation types. |
Anti-COVID-19 S-hIgG1 Neutralizing Antibody |
|||
E38A9970 | EnoGene | 100ug/100ul | EUR 225 |
Description: Available in various conjugation types. |
Anti-COVID-19 S-mIgG1 Neutralizing Antibody |
|||
E38A9971 | EnoGene | 100ug/100ul | EUR 225 |
Description: Available in various conjugation types. |
Anti-COVID-19 S-cIgG1 Neutralizing Antibody |
|||
E38A9972 | EnoGene | 100ug/100ul | EUR 225 |
Description: Available in various conjugation types. |
human anti-CPV neutralizing mAb |
|||
E4A09V04 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-FPV neutralizing mAb |
|||
E4A09V05 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG1 (AS35) |
|||
SAD-S35 | ACROBIOSYSTEMS | 100ug | EUR 2974.6 |
Description: Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG1 (AS35) (SAD-S35) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). This antibody recognizes the SARS-CoV-2 Spike Protein RBD domain and inhibits the interaction between SARS-CoV-2 RBD and ACE2 with an IC50 of 1.47 μg/mL using SARS-CoV-2 Inhibitor Screening Kit.Pseudovirus assay shows that this antibody has potent neutralizing activity against pseudovirus bearing SARS-CoV-2 Spike protein. |
Anti-NGF (Nerve Growth Factor) Neutralizing Antibody |
|||
100436-1 | BPS Bioscience | 50 µg | EUR 355 |
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species. |
Anti-NGF (Nerve Growth Factor) Neutralizing Antibody |
|||
100436-2 | BPS Bioscience | 100 µg | EUR 490 |
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species. |
Anti-PD-1 Neutralizing Antibody, Biotin-labeled |
|||
71215 | BPS Bioscience | 100 µg | EUR 510 |
Description: Purified, recombinant, human anti-PD-1 (IgG1) antibody with C-terminal Avitag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody does not cross-react with mouse PD-1, but does cross-react with monkey (M. fascicularis) PD-1. It has not been tested with other species. |
Anti-2019-nCoV S-IgM Neutralizing Antibody (8A5) |
|||
EPT006 | ELK Biotech | 50ug | EUR 239.4 |
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-2019-nCoV S-IgA Neutralizing Antibody (8A5) |
|||
EPT018 | ELK Biotech | 50ug | EUR 239.4 |
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-PD-L1 Neutralizing Antibody, Biotin-labeled |
|||
71214 | BPS Bioscience | 100 µg | EUR 510 |
Description: Purified, recombinant, chimeric murine/human anti-PD-L1 (IgG1) antibody with C-terminal Avi-tag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody reacts with human PD-L1 and cross-reacts with mouse PD-L1. It has not been tested for cross-reactivity with other species. |